These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 35712073)

  • 41. Chemotherapeutic and targeted drugs-induced immunogenic cell death in cancer models and antitumor therapy: An update review.
    Zhai J; Gu X; Liu Y; Hu Y; Jiang Y; Zhang Z
    Front Pharmacol; 2023; 14():1152934. PubMed ID: 37153795
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The "Yin and Yang" of Unfolded Protein Response in Cancer and Immunogenic Cell Death.
    Rufo N; Yang Y; De Vleeschouwer S; Agostinis P
    Cells; 2022 Sep; 11(18):. PubMed ID: 36139473
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Stimuli-responsive nanodelivery systems for amplifying immunogenic cell death in cancer immunotherapy.
    Xu W; Liu W; Yang J; Lu J; Zhang H; Ye D
    Immunol Rev; 2024 Jan; 321(1):181-198. PubMed ID: 37403660
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Aptamer-conjugated nano-liposome for immunogenic chemotherapy with reversal of immunosuppression.
    Kim M; Lee JS; Kim W; Lee JH; Jun BH; Kim KS; Kim DE
    J Control Release; 2022 Aug; 348():893-910. PubMed ID: 35760233
    [TBL] [Abstract][Full Text] [Related]  

  • 45. PAMAM Dendritic Nanoparticle-Incorporated Hydrogel to Enhance the Immunogenic Cell Death and Immune Response of Immunochemotherapy.
    Hanurry EY; Birhan YS; Darge HF; Mekonnen TW; Arunagiri V; Chou HY; Cheng CC; Lai JY; Tsai HC
    ACS Biomater Sci Eng; 2022 Jun; 8(6):2403-2418. PubMed ID: 35649177
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Immunogenic Cell Death: A Step Ahead of Autophagy in Cancer Therapy.
    Gupta G; Borglum K; Chen H
    J Cancer Immunol (Wilmington); 2021; 3(1):47-59. PubMed ID: 34263254
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Current and Future Therapies for Immunogenic Cell Death and Related Molecules to Potentially Cure Primary Breast Cancer.
    Kim R; Kin T
    Cancers (Basel); 2021 Sep; 13(19):. PubMed ID: 34638242
    [TBL] [Abstract][Full Text] [Related]  

  • 48. cGAS/STING axis mediates a topoisomerase II inhibitor-induced tumor immunogenicity.
    Wang Z; Chen J; Hu J; Zhang H; Xu F; He W; Wang X; Li M; Lu W; Zeng G; Zhou P; Huang P; Chen S; Li W; Xia LP; Xia X
    J Clin Invest; 2019 Aug; 129(11):4850-4862. PubMed ID: 31408442
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Decoding immunogenic cell death from a dendritic cell perspective.
    Janssens S; Rennen S; Agostinis P
    Immunol Rev; 2024 Jan; 321(1):350-370. PubMed ID: 38093416
    [TBL] [Abstract][Full Text] [Related]  

  • 50. 5-ALA mediated photodynamic therapy with combined treatment improves anti-tumor efficacy of immunotherapy through boosting immunogenic cell death.
    Sun Z; Zhao M; Wang W; Hong L; Wu Z; Luo G; Lu S; Tang Y; Li J; Wang J; Zhang Y; Zhang L
    Cancer Lett; 2023 Feb; 554():216032. PubMed ID: 36493899
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Targeting purinergic pathway to enhance radiotherapy-induced immunogenic cancer cell death.
    Bao X; Xie L
    J Exp Clin Cancer Res; 2022 Jul; 41(1):222. PubMed ID: 35836249
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Nanopulse Stimulation (NPS) Induces Tumor Ablation and Immunity in Orthotopic 4T1 Mouse Breast Cancer: A Review.
    Beebe SJ; Lassiter BP; Guo S
    Cancers (Basel); 2018 Mar; 10(4):. PubMed ID: 29601471
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Immunogenic cell death mediation patterns reveal novel paradigm for characterizing the immune microenvironment and immunotherapeutic responses in bladder cancer.
    Fu J; Zhang W; Jiang T
    Front Genet; 2022; 13():1035484. PubMed ID: 36386817
    [No Abstract]   [Full Text] [Related]  

  • 54. Pan-cancer analyses of immunogenic cell death-derived gene signatures: Potential biomarkers for prognosis and immunotherapy.
    Han X; Song D; Cui Y; Shi Y; Gu X
    Cancer Rep (Hoboken); 2024 Apr; 7(4):e2073. PubMed ID: 38627900
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Targeting immunogenic cell death in cancer.
    Ahmed A; Tait SWG
    Mol Oncol; 2020 Dec; 14(12):2994-3006. PubMed ID: 33179413
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Research progress in inducing immunogenic cell death of tumor cells.
    Xie D; Wang Q; Wu G
    Front Immunol; 2022; 13():1017400. PubMed ID: 36466838
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Inhibition of phospholipase D1 induces immunogenic cell death and potentiates cancer immunotherapy in colorectal cancer.
    Hwang WC; Song D; Lee H; Oh C; Lim SH; Bae HJ; Kim ND; Han G; Min DS
    Exp Mol Med; 2022 Sep; 54(9):1563-1576. PubMed ID: 36131027
    [TBL] [Abstract][Full Text] [Related]  

  • 58. In situ immunogenic clearance induced by a combination of photodynamic therapy and rho-kinase inhibition sensitizes immune checkpoint blockade response to elicit systemic antitumor immunity against intraocular melanoma and its metastasis.
    Kim S; Kim SA; Nam GH; Hong Y; Kim GB; Choi Y; Lee S; Cho Y; Kwon M; Jeong C; Kim S; Kim IS
    J Immunother Cancer; 2021 Jan; 9(1):. PubMed ID: 33479026
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Switching from Apoptosis to Pyroptosis: Gasdermin-Elicited Inflammation and Antitumor Immunity.
    Tsuchiya K
    Int J Mol Sci; 2021 Jan; 22(1):. PubMed ID: 33406603
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Amplifying "eat me signal" by immunogenic cell death for potentiating cancer immunotherapy.
    Xi Y; Chen L; Tang J; Yu B; Shen W; Niu X
    Immunol Rev; 2024 Jan; 321(1):94-114. PubMed ID: 37550950
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.